Eli Lilly and Company’s Olumiant (baricitinib) has been recommended for approval in Europe for adolescents with severe ...

Discover how high-throughput antibody screening accelerates therapeutic and vaccine development, enabling faster biologics ...

Atrium Therapeutics Inc. has launched as a newly independent, publicly traded company dedicated to delivering RNA therapeutics.

SK bioscience, IDT Biologika, and Vaxxas will collaborate on a next-generation influenza vaccine development initiative.

WuXi XDC Cayman Inc. has entered a strategic collaboration with Earendil Labs on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform.

Nexus Precision Health, a precision medicine technology company, has acquired Leal Health, an AI-powered patient ...

Alkermes, a global biopharmaceutical company headquartered in Ireland, is transitioning to a new Chief Executive Officer (CEO ...

Asahi Kasei Pharma has entered an exclusive global license agreement with Alchemedicine covering novel lead compounds for a ...

Learn why Water for Injection (WFI) is a strategic utility in sterile drug manufacturing and how outsourcing WFI production ...

AbbVie is investing $380 million to build two new active pharmaceutical ingredient (API) manufacturing facilities at its ...

Astellas Pharma Inc. and Vir Biotechnology Inc. have entered into a global strategic collaboration to advance VIR-5500.

Avid Bioservices Inc., a dedicated biologics CDMO, has opened its new Early Phase Center of Excellence, a 78,000 square foot ...